Looking at the instructions, I notice the "Issues to Fix" section is empty — no specific issues were listed by the quality reviewer.
Since there are no issues to fix, I'll return the original blog post body unchanged, as the instructions say to fix only the issues listed.
Aetna, a CVS Health company, modified CPB 0593 for aerosolized and irrigated anti-infectives for sinusitis, effective December 4, 2025. Here's what billing teams need to know.
Aetna's Aerosolized or Irrigated Anti-infectives for Sinusitis coverage policy — CPB 0593 Aetna — classifies nasal aerosolized and irrigated anti-infective therapy as experimental, investigational, or unproven across all sinusitis indications. The policy directly affects HCPCS codes E0574, E0575, E0580, and E0585 (nebulizer and aerosol generator equipment) and spans more than 100 ICD-10-CM diagnosis codes covering both acute and chronic sinusitis. If your DME suppliers or ENT practices are billing these codes for Aetna members with sinusitis diagnoses, this update draws a hard line.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Aerosolized or Irrigated Anti-infectives for Sinusitis |
| Policy Code | CPB 0593 |
| Change Type | Modified |
| Effective Date | December 4, 2025 |
| Impact Level | High — blanket experimental designation means zero reimbursement path |
| Specialties Affected | ENT/Otolaryngology, Allergy & Immunology, DME suppliers, Home Health |
| Key Action | Audit all active claims and orders for E0574, E0575, E0580, E0585 tied to J01.x and J32.x diagnoses before billing Aetna members |
Aetna Aerosolized Anti-infectives for Sinusitis Coverage Criteria and Medical Necessity Requirements 2025
The short answer: there are no coverage criteria that satisfy medical necessity for this treatment under Aetna's CPB 0593. Aetna finds the clinical evidence inadequate to support nasal aerosolized or irrigated anti-infective therapy for sinusitis. There is no threshold of documentation, no step therapy protocol, and no prior authorization pathway that unlocks coverage here.
This is a blanket experimental designation. It does not matter whether the patient has failed oral antibiotics, whether an ENT has documented chronic sinusitis for years, or whether the prescribing physician has written a detailed letter of medical necessity. Aetna's position is that the clinical literature does not support this approach — full stop.
This coverage policy applies to sinusitis broadly. The 100+ ICD-10-CM codes in scope span acute maxillary sinusitis (J01.0x), acute frontal sinusitis (J01.1x), acute ethmoidal sinusitis (J01.2x), acute sphenoidal sinusitis (J01.3x), acute pansinusitis (J01.4x), other acute sinusitis (J01.5x), and the full range of chronic sinusitis codes under J32.x. If the diagnosis touches the sinuses and the treatment involves aerosolized or irrigated anti-infectives, it is not covered.
Regarding prior authorization: it is not listed as a requirement here, because prior auth implies a coverage path exists. It does not. Do not advise your providers to pursue prior auth expecting a different result. That path ends in a claim denial regardless.
Aetna Aerosolized Anti-infectives for Sinusitis Exclusions and Non-Covered Indications
The entire treatment category is excluded under this coverage policy. Aetna considers nasally aerosolized or irrigated anti-infectives experimental, investigational, or unproven for sinusitis and all other indications listed in CPB 0593.
The four HCPCS codes explicitly designated as "not covered for indications listed in the CPB" are:
| # | Excluded Procedure |
|---|---|
| 1 | E0574 — Ultrasonic/electronic aerosol generator with small volume nebulizer |
| 2 | E0575 — Nebulizer, ultrasonic, large volume |
| 3 | E0580 — Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter |
| 4 | E0585 — Nebulizer, with compressor and heater |
These are durable medical equipment codes. If your DME suppliers are billing any of these against a sinusitis ICD-10 for an Aetna member, stop. Every one of those claims will deny.
The real exposure here is in home health and DME billing. Patients prescribed nebulizer therapy for upper respiratory conditions often have sinusitis listed as a comorbidity or primary diagnosis. Review your charge capture workflows to make sure sinusitis diagnoses are not being appended to nebulizer orders for Aetna members when anti-infective delivery is the intent.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Nasal aerosolized anti-infectives for sinusitis | Not Covered — Experimental | E0574, E0575, E0580, E0585; J01.x, J32.x | Blanket exclusion — no prior auth pathway |
| Irrigated anti-infectives for sinusitis | Not Covered — Experimental | E0574, E0575, E0580, E0585; J01.x, J32.x | Applies to all sinusitis types listed in CPB 0593 |
| Aerosolized or irrigated anti-infectives for other indications | Not Covered — Experimental | E0574, E0575, E0580, E0585 | Policy extends to other unspecified indications beyond sinusitis |
| Nebulizer demonstration/patient education (CPT 94664) | Related — not independently affected by exclusion | CPT 94664 | Listed as related CPT; coverage depends on underlying indication |
| Home respiratory therapy visit (CPT 99503) | Related — not independently affected by exclusion | CPT 99503 | Listed as related CPT; coverage depends on underlying indication |
Aetna Aerosolized Anti-infectives Billing Guidelines and Action Items 2025
The effective date is December 4, 2025. These action items should be completed now, not after you see the first denial wave.
| # | Action Item |
|---|---|
| 1 | Pull all open orders for E0574, E0575, E0580, and E0585 tied to sinusitis diagnoses for Aetna members. Check both active and pending claims. Any order with a J01.x or J32.x primary or secondary diagnosis and a nebulizer code in scope should be flagged before submission. |
| 2 | Update your charge capture rules to block E0574, E0575, E0580, and E0585 from auto-populating when sinusitis ICD-10 codes are the diagnosis on Aetna claims. This is a system configuration task. Assign it to your charge capture team with a deadline before December 4, 2025. |
| 3 | Review claims submitted between November 1 and December 4, 2025. If you have pending claims in this window using these codes, assess your exposure. The modified policy effective date is December 4, but clean claims submitted before that date may still process under prior policy language — confirm with Aetna's provider relations line before assuming those claims are safe. |
| 4 | Notify your ENT, allergy, and home health providers of this coverage policy change. Providers ordering nebulizer-based anti-infective therapy for sinusitis patients need to know Aetna will not reimburse it. They should document a different treatment plan for Aetna members or counsel patients on out-of-pocket costs if they want this therapy. |
| 5 | Differentiate sinusitis anti-infective delivery from bronchospasm or asthma nebulizer therapy on mixed-diagnosis patients. If a patient has both asthma (covered nebulizer indication) and sinusitis, your documentation must show the nebulizer is being used for the covered indication. If the anti-infective is intended for the sinuses, Aetna aerosolized anti-infectives billing rules apply and the claim denies. |
| 6 | Check CPB 0065 (Nebulizers) for related coverage rules. Aetna cross-references CPB 0065 in this policy. Your billing team should review that policy alongside CPB 0593 when any claim involves both nebulizer equipment and respiratory diagnoses. |
| 7 | Talk to your compliance officer if your practice treats a high volume of chronic sinusitis patients with Aetna coverage. If aerosolized anti-infective therapy has been part of your standard protocol, you may have a pattern of claims that are now at risk for retroactive review. A compliance officer can help you assess that exposure before it becomes a bigger problem. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Aerosolized Anti-infectives for Sinusitis Under CPB 0593
Not Covered HCPCS Codes — Experimental for Sinusitis Indications
These four codes are explicitly designated as not covered for indications listed in CPB 0593. Do not submit these against sinusitis diagnoses for Aetna members expecting reimbursement.
| Code | Type | Description | Status |
|---|---|---|---|
| E0574 | HCPCS | Ultrasonic/electronic aerosol generator with small volume nebulizer | Not covered — experimental |
| E0575 | HCPCS | Nebulizer, ultrasonic, large volume | Not covered — experimental |
| E0580 | HCPCS | Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter | Not covered — experimental |
| E0585 | HCPCS | Nebulizer, with compressor and heater | Not covered — experimental |
Related CPT and HCPCS Codes
These codes are listed in CPB 0593 as related to the policy. They are not independently excluded, but their coverage depends on the underlying indication. Billing these against sinusitis anti-infective indications for Aetna members carries the same denial risk.
| Code | Type | Description |
|---|---|---|
| CPT 94664 | CPT | Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler |
| CPT 99503 | CPT | Home visit for respiratory therapy care (e.g., bronchodilator, oxygen therapy, respiratory assessment) |
| A7013 | HCPCS | Filter, disposable, used with aerosol compressor |
| A7014 | HCPCS | Filter, non-disposable, used with aerosol compressor or ultrasonic generator |
| A7015 | HCPCS | Aerosol mask, used with DME nebulizer |
| E0572 | HCPCS | Aerosol compressor, adjustable pressure, light duty for intermittent use |
Key ICD-10-CM Diagnosis Codes in Scope
CPB 0593 covers more than 100 ICD-10-CM sinusitis codes. The full scope includes acute sinusitis across all anatomical subtypes (J01.x series) and chronic sinusitis variants (J32.x series). The table below lists the confirmed codes from the policy data. Assume any sinusitis code — acute or chronic — falls under this exclusion.
| Code | Description |
|---|---|
| J01.0 | Acute maxillary sinusitis, unspecified |
| J01.10 | Acute frontal sinusitis, unspecified |
| J01.11 | Acute recurrent frontal sinusitis |
| J01.12 | Acute frontal sinusitis (variant) |
| J01.13 | Acute frontal sinusitis (variant) |
| J01.14 | Acute frontal sinusitis (variant) |
| J01.15 | Acute frontal sinusitis (variant) |
| J01.16 | Acute frontal sinusitis (variant) |
| J01.17 | Acute frontal sinusitis (variant) |
| J01.18 | Acute frontal sinusitis (variant) |
| J01.19 | Acute frontal sinusitis (variant) |
| J01.2 | Acute ethmoidal sinusitis, unspecified |
| J01.20–J01.29 | Acute ethmoidal sinusitis variants |
| J01.3 | Acute sphenoidal sinusitis, unspecified |
| J01.30–J01.39 | Acute sphenoidal sinusitis variants |
| J01.4 | Acute pansinusitis, unspecified |
| J01.40–J01.49 | Acute pansinusitis variants |
| J01.5 | Other acute sinusitis |
| J01.50–J01.59 | Other acute sinusitis variants |
| J01.6–J01.7 | Acute sinusitis variants |
| J01.60–J01.70 | Acute sinusitis (additional variants) |
The full ICD-10 code list in CPB 0593 includes 102 codes. Treat all J01.x and J32.x sinusitis codes as within scope for this exclusion when billing Aetna.
Get the Full Picture for CPT 94664
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.